ALDR Stock Hits 2-Year High on Lundbeck Acquisition News

ALDR stock

ALDR stock is the biggest gainer in the biotech space on the news that H. Lundbeck A/S will acquire Alder BioPharmaceuticals Inc (NASDAQ:ALDR) for $2 billion.

Solid Boost for Shareholders

When it comes to the biggest pharmaceutical companies in the world, then it is a well-known fact that many of those companies use mergers and acquisition as a path to further growth. Acquisitions help large companies to come into possession of lucrative drugs, which in turn leads to more growth, and that is what Danish pharmaceutical company Lundbeck has done.

In a fresh development, ...

Read The Full Article On

Get early insight on hidden secret gems on MicroSmallCap. Follow Crypto, Mining, Cannabis and Energy stocks and get free research reports here.

All content provided by MicroSmallCap is subject to our Terms Of Use and Disclaimer.

Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.